Riskpilot← Back to searchSign inGet full accessBT ORTOPEDI AS
ASActiveOrg 957547281Ingeniør Rybergs Gate 114, 3027 DrammenManufacture of medical and dental instruments and supplies · NACE 3250Est. 199014 employees
Revenue 2024
NOK 27,1M
+8% vs 2023
EBITDA margin
-2.1%
-134% vs 2023
Equity ratio
43.0%
Financial strength
Net profit 2024
NOK -589K
-150% vs 2023
| Revenue | NOK 27,1M | +8% |
| EBITDA | NOK -566K | -134% |
| Net profit | NOK -589K | -150% |
| Total assets | NOK 9,6M | -4% |
| Equity | NOK 4,1M | -12% |
| Employees | 14 | — |
Legal name
BT ORTOPEDI AS
Org number
957547281
Legal form
Aksjeselskap
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
10. mai 1990
Share capital
NOK 1 200 000
Employees
14 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Address
Ingeniør Rybergs Gate 114, 3027 Drammen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12 596 | 13 693 | 18 402 | 13 448 | 13 071 | 14 391 | 16 384 | 17 000 | 14 760 | 14 668 | 14 155 | 21 042 | 19 737 | 25 040 | 27 081 |
| Staff expenses | −4 274 | −4 497 | −3 766 | −4 277 | −4 516 | −5 038 | −5 228 | −5 615 | −5 462 | −6 050 | −6 327 | −8 045 | −8 311 | −10 191 | −12 030 |
| EBITDA | 546 | 158 | 1 625 | 331 | 723 | 732 | 1 572 | 1 815 | 562 | −59 | −213 | 462 | 1 236 | 1 657 | −566 |
| Depreciation & amort. | −225 | −203 | −144 | −156 | −146 | −160 | −172 | −172 | −114 | −127 | −183 | −194 | −129 | −83 | −92 |
| EBIT | 321 | −44 | 1 481 | 175 | 577 | 572 | 1 401 | 1 643 | 447 | −185 | −396 | 268 | 1 107 | 1 574 | −658 |
| Net financials | −123 | −52 | −49 | −78 | 90 | 42 | 104 | 143 | 329 | 1 332 | 59 | −30 | −55 | −56 | −95 |
| Profit before tax | 198 | −96 | 1 432 | 97 | 667 | 614 | 1 504 | 1 786 | 776 | 1 146 | −337 | 238 | 1 052 | 1 518 | −753 |
| Tax | 55 | −30 | 404 | 31 | 143 | 141 | 342 | 391 | 106 | −42 | −54 | 53 | 231 | 334 | −163 |
| Net profit | 143 | −66 | 1 028 | 66 | 524 | 473 | 1 163 | 1 395 | 670 | 1 188 | −282 | 185 | 821 | 1 184 | −589 |
| Item | 2008 | 2009 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4 887 | 4 548 | 7 000 | 6 705 | 6 928 | 7 485 | 9 182 | 8 330 | 9 802 | 13 675 | 15 360 | 8 813 | 9 680 | 10 053 | 9 605 |
| Equity | 768 | 702 | 2 808 | 2 874 | 3 398 | 3 871 | 4 733 | 5 808 | 6 328 | 6 816 | 6 534 | 3 718 | 4 539 | 4 723 | 4 133 |
| Long-term debt | 1 635 | 1 156 | 789 | 1 224 | 1 038 | 836 | 609 | 557 | 495 | 380 | 226 | 111 | 16 | 0 | 0 |
| Short-term debt | 2 484 | 2 691 | 3 403 | 2 607 | 2 492 | 2 779 | 3 839 | 1 965 | 2 979 | 6 479 | 8 600 | 4 983 | 5 125 | 5 331 | 5 472 |
| Total debt | 4 119 | 3 847 | 4 191 | 3 831 | 3 530 | 3 614 | 4 448 | 2 522 | 3 474 | 6 859 | 8 826 | 5 094 | 5 141 | 5 331 | 5 472 |
EBITDA margin
-2.1%
This company
15.8%
Market median
-113% vs market
20082024
Equity ratio
43.0%
This company
38.2%
Market median
+13% vs market
20082024
Return on equity
-14.3%
This company
18.4%
Market median
-178% vs market
20082024
Net profit margin
-2.2%
This company
8.1%
Market median
-127% vs market
20082024
Asset turnover
2.82×
This company
1.12×
Market median
+152% vs market
20082024
Debt / equity
1.32×
This company
0.62×
Market median
-113% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NB Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
IL Chief Executive Officer | Chief Executive Officer | 2007 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Cannac Holding As | Company | 75.0% | 75.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bodlyn As
BT ORTOPEDI AS Board members of BT ORTOPEDI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Botnmark | Chief Executive Officer | 0 companies |
| Ingvar Lennart Beck | Chief Executive Officer | 0 companies |
| Audun Hildre Schevik | Board of Directors | 0 companies |
| Halvard Kristoffer Rype | Chairman | 0 companies |
| Thomas Babintsev Skorstad | Chairman | 0 companies |
| Alexander Schjøttelvig Skevakis | Board of Directors | 0 companies |
| Christopher Alan Greenway | Board of Directors | 0 companies |
| Karl-Tomas Lyngroth | Board of Directors | 0 companies |